Diseases / Research

Lymphoma

Hodgkin Lymphoma

Most of the cells pictured here are normal and represent an robust inflammatory reaction to the few large atypical “Reed Sternberg” cells. The Reed Sternberg cells are the large atypical cells and often have 2 separate nuclei with central red nucleoli giving the classic forms an appearance often describe as “Owl eyes”

Photo by Keith Loeb, PhD, and Sindhu Cherian, MD, SCCA Department of Pathology

Lymphoma refers to a a group of cancers that strike the lymphatic system, which is a key part of the immune system. Lymphomas are broadly classified as either Hodgkins or non-Hodgkins. Some lymphomas are highly curable; others require complex treatment.

Fred Hutch pioneered bone marrow transplantation as a treatment for lymphoma, leukemia and other cancers, amd our scientists are developing promising new lymphoma therapies. Today,  Hutch is pursuing new treatments such as cord blood transplantation.

Learn more about the our research on the two major types of lymphoma:

  • Hodgkin
    Hodgkin lymphoma is marked by the presence of the Reed-Sternberg cell, a large cell that increases in number as the disease advances. Hodgkin lymphoma is highly curable with a survival rate that is considered very high.

  • Non-Hodgkin
    There are several types of Non-Hodgkin lymphomas that are typically characterized as fast or slow-growing and as originating from T-cells or B-cells, both of which are types of white blood cells. Prognosis and treatment depend on the disease's stage and type.

Make an Appointment

Patients have access to cancer treatment developed by Fred Hutch at the Seattle Cancer Care Alliance, our clinical care partner.


Find a Trial

Clinical trials are vital to the development of innovative treatments for cancer and other related diseases.


Volunteer for a Study

Volunteers play a key role in prevention and early detection research.

GIVE NOW &
SAVE LIVES

Support our quest for cures